Emergent BioSolutions raises 2025 guidance to $835M revenue and $210M EBITDA as international MCM sales surge (NYSE:EBS) - Reportify

Emergent BioSolutions raises 2025 guidance to $835M revenue and $210M EBITDA as international MCM sales surge (NYSE:EBS)

Emergent BioSolutions(US:EBS) Seeking Alpha·2025-10-30 00:57

根据提供的文档内容，该文档不包含任何与公司或行业相关的实质性信息文档内容仅为一条技术性提示要求用户启用浏览器中的Javascript和cookies 并可能需禁用广告拦截器以继续操作 [1]